Biotin
In clinical developmentAlso known as Appearex, Coenzyme R, Concept OB, Dialyvite 800+19 more
Appearex, Coenzyme R, Concept OB, Dialyvite 800, Dialyvite 800 + Iron, Dialyvite 800 with Iron, Dialyvite 800 with Zinc, Hemax, Infuvite, Infuvite Pediatric, Irospan Tablet, Lexinal, Nephrocaps, Nephrocaps QT, Prenatal Rx 1, Vitabee with C, Vitamin B7, Vitamin H, Biotina, Biotine, Biotinum, cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid, cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid.
Recent clinical, regulatory, research and industry developments relating to this drug.
A Streptomyces megacluster encodes synergistic biotin-targeting antibiotics
Can Biotin Supplementation be Used to Mask hCG Abuse?
Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis
Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- The Journal of neuroscience : the official journal of the Society for Neuroscience1
- Lee HG1
- Li X1
- Perry G1
- Smith MA1
- Su B1
- Wang X1
- Zhu X1
- Case Western Reserve University1
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials